Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen A Lauer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|August 28, 2021
Clinical Cholera Surveillance Sensitivity in Bangladesh and Implications for Large-Scale Disease ControlSonia T Hegde, Elizabeth C Lee, Ashraful Islam Khan, et al.
Nature Communications|June 16, 2021
Insights into household transmission of SARS-CoV-2 from a population-based serological surveyQifang Bi, Justin Lessler, Isabella Eckerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Triggering interventions for influenza: the ALERT algorithmNicholas G Reich, Derek A T Cummings, Stephen A Lauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010-2014Stephen A Lauer, Krzysztof Sakrejda, Evan L Ray, et al.
Scientific Reports|April 7, 2021
A scenario modeling pipeline for COVID-19 emergency planningJoseph C Lemaitre, Kyra H Grantz, Joshua Kaminsky, et al.
The Lancet. Microbe|December 21, 2020
<i>Vibrio cholerae</i> O1 transmission in Bangladesh: insights from a nationally representative serosurveyAndrew S Azman, Stephen A Lauer, Taufiqur Rahman Bhuiyan, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
MMWR. Morbidity and Mortality Weekly Report|May 14, 2021
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021Rebecca K Borchering, Cécile Viboud, Emily Howerton, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|August 28, 2021
Clinical Cholera Surveillance Sensitivity in Bangladesh and Implications for Large-Scale Disease ControlSonia T Hegde, Elizabeth C Lee, Ashraful Islam Khan, et al.
Nature Communications|June 16, 2021
Insights into household transmission of SARS-CoV-2 from a population-based serological surveyQifang Bi, Justin Lessler, Isabella Eckerle, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 22, 2014
Triggering interventions for influenza: the ALERT algorithmNicholas G Reich, Derek A T Cummings, Stephen A Lauer, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2018
Prospective forecasts of annual dengue hemorrhagic fever incidence in Thailand, 2010-2014Stephen A Lauer, Krzysztof Sakrejda, Evan L Ray, et al.
Scientific Reports|April 7, 2021
A scenario modeling pipeline for COVID-19 emergency planningJoseph C Lemaitre, Kyra H Grantz, Joshua Kaminsky, et al.
The Lancet. Microbe|December 21, 2020
<i>Vibrio cholerae</i> O1 transmission in Bangladesh: insights from a nationally representative serosurveyAndrew S Azman, Stephen A Lauer, Taufiqur Rahman Bhuiyan, et al.
Lancet (London, England)|June 15, 2020
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studySilvia Stringhini, Ania Wisniak, Giovanni Piumatti, et al.
Medrxiv : the Preprint Server for Health Sciences|August 4, 2020
Dynamics and significance of the antibody response to SARS-CoV-2 infectionAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
Science Immunology|October 9, 2020
Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patientsAnita S Iyer, Forrest K Jones, Ariana Nodoushani, et al.
MMWR. Morbidity and Mortality Weekly Report|May 14, 2021
Modeling of Future COVID-19 Cases, Hospitalizations, and Deaths, by Vaccination Rates and Nonpharmaceutical Intervention Scenarios - United States, April-September 2021Rebecca K Borchering, Cécile Viboud, Emily Howerton, et al.
Pageof 3